ADVFN Logo ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
0,00
0,00
(0,00%)
Chiuso 21 Aprile 5:30PM

Il tuo punto di riferimento per quotazioni in tempo reale, idee e discussioni live.

Notizie su CML

Solo notizie ufficiali
MiamiGent MiamiGent 5 minuti fa
I'm three behind ya, Sem. It's going fast enough...
One day I woke up and the I was, old.

Wonder who the new Pope will be
Pnypnchr Pnypnchr 5 minuti fa
Your buddy Biden built 1for billions of dollars. LMAO 
Where did that money go?
TSLA
PEACHMAN PEACHMAN 6 minuti fa
In my opinion,IFUS news in April and the rest of 2025 will continue to validate that IFUS management is building IFUS the right way that will reward all shareholders in the Future.

Share these links with others or review them again yourself.

The science and manufacturin
IFUS
nssrr5 nssrr5 6 minuti fa
I will do my best LOL
TSLA
Kentucky123 Kentucky123 6 minuti fa
Thank you Hoskuld for your well considered response. Makes sense.
AVXL
PennyMillions852 PennyMillions852 6 minuti fa
So where we headed??
CAVR
NovaChimera99 NovaChimera99 7 minuti fa
they seemed real, can they fake file the fact that they own the company they had 49% of the stock the 3 of them or 4 before dilution

One is siri info owner, other is siri health coo, Ignatus doupaty

other owns a Chinese garment or clothes business which makes indian clo
CNTM
nssrr5 nssrr5 7 minuti fa
It's not just in here - in my industry which I am trying to leave out of this conversation but we sell equipment to the biggest industry in the world and the main focus for the last five years is on companies buying the new technology to eliminate people. It has made me a lot of money at the cost
TSLA
PennyMillions852 PennyMillions852 7 minuti fa
Looks scammish….4 months into the new year and still no PPS movement, just failed pumps by pump posters here….
BIEI
louieforpar louieforpar 8 minuti fa
The setting of fires and the discharging of weapons in public no less a crowded area is common for other countries. 
However, our government as we currently know it will soon become such. 

Good to know how they feel nonetheless. 
sctts sctts 9 minuti fa
$$$ Today is the Day $$$$

$$$$ $FRX $$$
FRX
sab63090 sab63090 9 minuti fa
Hoskuld: yep!

Those IB's are smart guys and want some sort of evidence and to think Missling has not applied for approval yet is telling
AVXL
NASDAQ2020 NASDAQ2020 10 minuti fa
Toppin off today
TWOH
jackson73 jackson73 14 minuti fa
SHFS ww low floater
SHFS
misterfishman misterfishman 16 minuti fa
Hey,watch your mouth don't talk to my big bro like that.keep it up and you will see what happens.
IGPK
ksquared ksquared 18 minuti fa
You've lived a wonderful life.
Keep it up. You're still in the swing of things.
Zardiw Zardiw 20 minuti fa
Palms Haven Recovery

https://PalmsHaven.com
https://PalmsHaven.com/Pictures/Palms5.jpg

Z
sab63090 sab63090 21 minuti fa
Reduce the deficit which is a big factor in reducing inflation; it's not destruction, it's prudent....

I'm not smart enough to debate tariffs, but I certainly recognize when something stinks. China has been abusing "the ongoing system" for many decades using child labor with American
AVXL
uranium-pinto-beans uranium-pinto-beans 21 minuti fa
VRNA
Cantor starts Verona at Overweight, says momentum 'just getting started'
Cantor Fitzgerald initiated coverage of Verona Pharma with an Overweight rating and $80 price target. The firm considers Verona one of the best stories in biotech. The firm believes Ohtuvayre's launch in c
VRNA
uranium-pinto-beans uranium-pinto-beans 21 minuti fa
VRNA
Cantor starts Verona at Overweight, says momentum 'just getting started'
Cantor Fitzgerald initiated coverage of Verona Pharma with an Overweight rating and $80 price target. The firm considers Verona one of the best stories in biotech. The firm believes Ohtuvayre's launch in c
VRNA
uranium-pinto-beans uranium-pinto-beans 21 minuti fa
MSFT
Microsoft price target lowered to $430 from $475 at Barclays
Barclays lowered the firm's price target on Microsoft to $430 from $475 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for U.S. software. The firm says Q1 "will unlikely be a major catal
MSFT
uranium-pinto-beans uranium-pinto-beans 22 minuti fa
NOW
ServiceNow price target lowered to $967 from $1,200 at Barclays
Barclays analyst Raimo Lenschow lowered the firm's price target on ServiceNow to $967 from $1,200 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for U.S. software. The firm says Q1 "wi

La tua Cronologia

Delayed Upgrade Clock